↓ Skip to main content

BRCA1/2 Sequence Variants of Uncertain Significance: A Primer for Providers to Assist in Discussions and in Medical Management

Overview of attention for article published in Oncologist, April 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
78 Mendeley
Title
BRCA1/2 Sequence Variants of Uncertain Significance: A Primer for Providers to Assist in Discussions and in Medical Management
Published in
Oncologist, April 2013
DOI 10.1634/theoncologist.2012-0452
Pubmed ID
Authors

Noralane M. Lindor, David E. Goldgar, Sean V. Tavtigian, Sharon E. Plon, Fergus J. Couch

Abstract

DNA variants of uncertain significance (VUS) are common outcomes of clinical genetic testing for susceptibility to cancer. A statistically rigorous model that provides a pathogenicity score for each variant has been developed to aid in the clinical management of patients undergoing genetic testing.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 1%
Italy 1 1%
Unknown 76 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 22%
Student > Ph. D. Student 11 14%
Student > Bachelor 10 13%
Other 8 10%
Researcher 8 10%
Other 11 14%
Unknown 13 17%
Readers by discipline Count As %
Medicine and Dentistry 25 32%
Agricultural and Biological Sciences 19 24%
Biochemistry, Genetics and Molecular Biology 13 17%
Nursing and Health Professions 3 4%
Social Sciences 2 3%
Other 2 3%
Unknown 14 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2017.
All research outputs
#16,737,737
of 25,394,764 outputs
Outputs from Oncologist
#3,019
of 3,985 outputs
Outputs of similar age
#126,363
of 206,009 outputs
Outputs of similar age from Oncologist
#24
of 44 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,985 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,009 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.